Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Fiji Kava Limited ( (AU:CCO) ) just unveiled an update.
The Calmer Co. has launched its Taki Mai kava tinctures on Amazon USA, marking a significant step in its expansion into the U.S. market. These tinctures, available in 1oz and 4oz bottles, are designed for modern wellness consumers and can be used directly or mixed into beverages. The launch positions The Calmer Co. as a leader in the growing kava category, with the Amazon tincture market valued at over US$11.16 million and growing at 18% annually. The company anticipates significant revenue growth from the U.S. market, which currently contributes 29% of its revenue, and aims to capitalize on the increasing demand for kava products.
More about Fiji Kava Limited
The Calmer Co. International Limited (ASX: CCO) is a fast-growing beverage company focusing on kava and other natural products that serve as alternatives to alcohol and support relaxation and sleep. The company distributes its products globally through e-commerce and retail partners, with a product range that includes drinking powders, kava shots, concentrates, and capsules under brands like Fiji Kava, Taki Mai, and Danodan Hempworks, in markets such as the USA, Australia, New Zealand, China, and the Pacific Islands.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.03M
For a thorough assessment of CCO stock, go to TipRanks’ Stock Analysis page.